Sai Life Sciences Limited has received an order from the Joint Commissioner of Commercial Taxes (Appeals), Kalaburagi, concerning a tax demand for the financial year 2021-22. The order pertains to allegations of excess availment of Input Tax Credit. The company intends to challenge this decision by filing an appeal and remains optimistic regarding a favorable outcome at the Tribunal level, noting no expected material financial impact on its operations.
Details of the Tax Order
On April 29, 2026, Sai Life Sciences Limited received an official order from the Joint Commissioner of Commercial Taxes (Appeals), Kalaburagi. The order outlines a total tax demand involving three specific components related to alleged discrepancies in Input Tax Credit utilized in GSTR-3B versus GSTR-2A records for the 2021-22 financial year.
Breakdown of Financial Claims
The total demand issued by the authorities includes the following financial liabilities:
- IGST: INR 16,28,46,397
- Interest: INR 13,31,50,353
- Penalty: INR 3,25,69,279
Management Stance and Outlook
In response to the development, the company has conducted an internal assessment of the matter. Management has confirmed its intention to pursue the legal process by filing an appeal with the relevant Tribunal. The company expressed confidence in a positive resolution and stated that the order is not expected to have any material financial impact on the company’s business activities or overall operations.
Source: BSE
